| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Ciprofloxacin | FAERS: 6 | US FAERS | |
| 2 | temsirolimus | FAERS: 5 | US FAERS | |
| 3 | treprostinil | FAERS: 3 | US FAERS | |
| 4 | Bendamustine Hydrochloride | FAERS: 2 | US FAERS | |
| 5 | Finasteride | FAERS: 2 | US FAERS | |
| 6 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 7 | Venlafaxine Hydrochloride | FAERS: 2 | US FAERS | |
| 8 | ambrisentan | FAERS: 2 | US FAERS | |
| 9 | apixaban | FAERS: 2 | US FAERS | |
| 10 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 11 | Albuterol | FAERS: 1 | US FAERS | |
| 12 | Aripiprazole | FAERS: 1 | US FAERS | |
| 13 | Aspirin | FAERS: 1 | US FAERS | |
| 14 | Bortezomib | FAERS: 1 | US FAERS | |
| 15 | Clarithromycin | FAERS: 1 | US FAERS | |
| 16 | Erythromycin | FAERS: 1 | US FAERS | |
| 17 | Everolimus | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 18 | N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine | FAERS: 1 | US FAERS | |
| 19 | NuvaRing | FAERS: 1 | US FAERS | |
| 20 | Octreotide | FAERS: 1 | US FAERS | |
| 21 | QVA149 | FAERS: 1 | US FAERS | |
| 22 | Quetiapine Fumarate | FAERS: 1 | US FAERS | |
| 23 | Umeclidinium bromide | FAERS: 1 | US FAERS | |
| 24 | Valsartan | FAERS: 1 | US FAERS | |
| 25 | candesartan | FAERS: 1 | US FAERS | |
| 26 | carfilzomib | FAERS: 1 | US FAERS | |
| 27 | ferrous sulfate | FAERS: 1 | US FAERS | |
| 28 | iodixanol | FAERS: 1 | US FAERS | |
| 29 | iopromide | FAERS: 1 | US FAERS | |
| 30 | macitentan | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.